“In working hearts, 10 micromol/L ranolazine significantly increased glucose oxidation 1.5-fold to 3-fold under conditions in which the contribution of glucose to overall ATP production was low (low Ca , high FA, with insulin), high (high Ca, low Fa, with pacing), or intermediate.”